OMERS ADMINISTRATION Corp acquired a new position in Xylem Inc. (NYSE:XYL – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 12,542 shares of the industrial products company’s stock, valued at approximately $1,483,000.
A number of other hedge funds have also bought and sold shares of the business. Wexford Capital LP bought a new stake in shares of Xylem during the 3rd quarter valued at $27,000. Commonwealth Retirement Investments LLC purchased a new stake in Xylem during the 4th quarter worth about $27,000. Dunhill Financial LLC bought a new position in Xylem in the 2nd quarter worth about $30,000. Avalon Trust Co bought a new position in Xylem in the 2nd quarter worth about $35,000. Finally, Entrust Financial LLC purchased a new position in Xylem during the 4th quarter valued at about $45,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Xylem Stock Performance
NYSE:XYL opened at $113.51 on Thursday. The business’s 50-day moving average price is $118.18 and its two-hundred day moving average price is $119.13. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The stock has a market cap of $26.50 billion, a P/E ratio of 27.03, a PEG ratio of 1.66 and a beta of 1.02. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.
Xylem Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th will be given a dividend of $0.43 per share. The ex-dividend date is Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s payout ratio is presently 40.95%.
Analyst Upgrades and Downgrades
XYL has been the topic of several analyst reports. Citigroup reiterated a “buy” rating on shares of Xylem in a research report on Wednesday, July 29th. Stifel Nicolaus boosted their price objective on shares of Xylem from $157.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, July 29th. Oppenheimer decreased their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. CLSA upgraded shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Xylem in a report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
